凤凰网首页 手机凤凰网

凤凰卫视
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
免费注册
北陆药业(300016)公告正文

北陆药业:2012年半年度报告摘要

公告日期 2012-08-03
股票简称:北陆药业 股票代码:300016
                                                                            2012 年半年度报告摘要
    证券代码:300016                   证券简称:北陆药业                    公告编号:2012-018
                                2012 年半年度报告摘要
                                      一、重要提示
       本公司董事会、监事会及董事、监事、高级管理人员保证本报告所载资料不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
       公司半年度财务报告未经会计师事务所审计。
       公司负责人王代雪、主管会计工作负责人李弘及会计机构负责人(会计主管人员)李弘声明:保证半年度报告中财务报告的真实、完整。
                                  二、公司基本情况简介
       (一)基本情况简介
    A 股简称                                                 北陆药业
    A 股代码                                                   300016
    法定代表人                                                 王代雪
    上市证券交易所                                        深圳证券交易所
       (二)联系人和联系方式
              项目                                      董事会秘书
    姓名                                                       刘宁
    联系地址                           北京市海淀区西直门北大街 32 号枫蓝国际写字楼 A 座 7 层
    电话                                                   010-62625287
    传真                                                   010-82626933
    电子信箱                                             blxp@beilu.com.cn
       (三)主要财务数据和指标
       1、主要会计数据
       以前报告期财务报表是否发生了追溯调整
       □ 是 √ 否
                                                                                            2012 年半年度报告摘要
    主要会计数据
                                                                                         本报告期比上年同期增减
             主要会计数据               报告期(1-6 月)             上年同期
                                                                                                   (%)
    营业总收入(元)                               126,890,389.00            88,714,242.47                     43.03
    营业利润(元)                                  32,771,037.47            22,063,305.66                     48.53
    利润总额(元)                                  35,157,274.55            22,956,788.66                     53.15
    归属于上市公司股东的净利润(元)                30,075,542.54            19,582,869.94                     53.58归属于上市公司股东的扣除非经常性损
                                                28,047,241.02            18,823,409.39                     49.00益的净利润(元)
    经营活动产生的现金流量净额(元)                -17,105,293.44           12,823,439.35                   -233.39
                                                                                         本报告期末比上年度期末
                                           本报告期末               上年度期末
                                                                                                 增减(%)
    总资产(元)                                   521,892,033.99           524,656,182.87                     -0.53
    归属于上市公司股东的所有者权益(元)           491,134,030.71           491,470,204.26                     -0.07
    股本(股)                                     152,749,104.00           152,749,104.00                      0.00
    主要财务指标
                                                                                         本报告期比上年同期增减
                 项目                         报告期                 上年同期
                                                                                                   (%)
    基本每股收益(元/股)                                       0.20                  0.13                     53.85
    稀释每股收益(元/股)                                       0.20                  0.13                     53.85扣除非经常性损益后的基本每股收益
                                                            0.18                  0.12                     50.00(元/股)
    加权平均净资产收益率(%)                                   6.06                  4.13                      1.93扣除非经常性损益后的加权平均净资产
                                                            5.65                  3.97                      1.68收益率(%)每股经营活动产生的现金流量净额(元/
                                                            -0.11                 0.08                    -237.5股)
                                                                                         本报告期末比上年度同期
                                             报告期末               上年度期末
                                                                                               末增减(%)归属于上市公司股东的每股净资产(元/
                                                            3.22                  3.22                        0股)
    资产负债率(%)                                             5.89                  3.09                      2.80
    2、非经常性损益项目
    √ 适用 □ 不适用
                                   非经常性损益项目                                      年初至报告期末金额(元)非流动资产处置损益越权审批或无正式批准文件的税收返还、减免计入当期损益的政府补助(与企业业务密切相关,按照国家统一标准定额或定量享受的政府补助
                                                                                                         2,660,131除外)计入当期损益的对非金融企业收取的资金占用费
                                                                                              2012 年半年度报告摘要企业取得子公司、联营企业及合营企业的投资成本小于取得投资时应享有被投资单位可辨认净资产公允价值产生的收益非货币性资产交换损益委托他人投资或管理资产的损益因不可抗力因素,如遭受自然灾害而计提的各项资产减值准备债务重组损益企业重组费用,如安置职工的支出、整合费用等交易价格显失公允的交易产生的超过公允价值部分的损益同一控制下企业合并产生的子公司期初至合并日的当期净损益与公司正常经营业务无关的或有事项产生的损益除同公司正常经营业务相关的有效套期保值业务外,持有交易性金融资产、交易性金融负债产生的公允价值变动损益,以及处置交易性金融资产、交易性金融负债和可供出售金融资产取得的投资收益单独进行减值测试的应收款项减值准备转回对外委托贷款取得的损益采用公允价值模式进行后续计量的投资性房地产公允价值变动产生的损益根据税收、会计等法律、法规的要求对当期损益进行一次性调整对当期损益的影响受托经营取得的托管费收入
    除上述各项之外的其他营业外收入和支出                                                                     -273,893.92其他符合非经常性损益定义的损益项目少数股东权益影响额
    所得税影响额                                                                                             -357,935.56
    合计                                                                                                    2,028,301.52
                                               三、董事会报告
       (一)主营业务分行业、产品情况表
                                                                                                         单位:元
                                                                     营业收入比上年 营业成本比上年 毛利率比上年同期
    分行业或分产品       营业收入       营业成本        毛利率(%)
                                                                     同期增减(%) 同期增减(%)       增减(%)分行业
    药品生产         126,243,687.10     31,904,997.17           74.73             45.79          47.09             -0.22
    药品经销                        -               -               --           -100.00        -100.00               --
    合计             126,243,687.10     31,904,997.17           74.73             45.71          46.81             -0.19分产品
    对比剂           119,222,182.91     29,254,840.01           75.46             43.72          43.76             -0.21
    降糖药                 966,926.94      328,964.3            65.97             -54.46         -53.26            -0.88
    九味镇心颗粒         6,054,577.25    2,321,192.86           61.66            299.53         264.12              3.73
    药品经销                     0.00            0.00               --           -100.00        -100.00               --
    合计             126,243,687.10     31,904,997.17           74.73             45.71          46.81             -0.19
       主营业务分行业和分产品情况的说明
       2012年1-6月药品经销收入为0元,2011年1-6月药品经销收入为4.34万元。
                                                                               2012 年半年度报告摘要
       报告期公司营业收入为 12,689.04 万元,其中主营业务收入 12,624.37 万元,其他业务收入 64.67 万元。营业收入较上年同期上升了 43.03%,主要是公司药品生产业务收入大幅增加45.79%所致,药品生产业务收入的快速增长主要受益于对比剂增长 43.72%以及九味镇心颗粒增长 299.53%的贡献。
       毛利率比上年同期增减幅度较大的原因说明
       报告期核心产品对比剂综合毛利率基本稳定,保持在 75%左右水平。九味镇心颗粒产品通过前期市场孕育效果显现,报告期较上年市场扩张的同时,产品产销量增大,不同规格的产品结构及价格较上年同期略有变动,产品单位成本略有下降,综合导致毛利率较上年同期上升 3.73 个百分点。
       (二)主营业务分地区情况
                                                                                          单位:元
               地区                      营业收入                   营业收入比上年同期增减(%)
    华东地区                                            40,299,479.58                           75.07%
    华南地区                                             9,544,904.76                           28.28%
    华中地区                                             9,052,055.06                           12.62%
    华北地区                                            43,305,969.36                           31.69%
    西北地区                                             3,035,354.23                           17.24%
    西南地区                                            11,447,239.72                           72.67%
    东北地区                                             9,558,684.39                           58.30%
    合计                                            126,243,687.10                              45.71%
       主营业务分地区情况的说明
       华东地区:山东、江苏、安徽、江西、浙江、福建、上海;
       华南地区:广东、广西、海南;华中地区:湖北、湖南;
       华北地区:北京、天津、河南、河北、山西、内蒙;
       西北地区:宁夏、新疆、青海、陕西、甘肃;
       西南地区:四川、云南、贵州、西藏;
       东北地区:黑龙江、吉林、辽宁。
       各业务区域的快速增长主要是营销体制改变后,区域业务管理得到有效整合。整合提高了市场管理效益,加快了市场的响应速度,取得了高于市场平均增幅的成果。
       主营业务构成情况的说明
       本报告期公司利润构成及主营业务的盈利能力未发生重大变化,药品生产业务依然是公
                                                                    2012 年半年度报告摘要司利润的主要来源,报告期药品生产业务实现利润总额 3,538.63 万元,较上年同期的 2,321.08万元上升 52.46%,主要是公司本期销量增加所致。
    公司当期营业收入为 12,689.04 万元,主营业务收入为 12,624.37 万元,占营业收入总额的 99.49%,较上年同期增加 45.71%;其他业务收入为 64.67 万元,占营业收入的 0.51%,较上年同期下降 68.85%。主营业务的产品营销是公司收入的主要来源,也是公司利润的根本。
    公司主营产品综合毛利率仍维持较高水平,达到 74.73%。主营产品销售增长的同时对比剂产品毛利维持上年同期水平、九味镇心颗粒产品毛利率较上年同期提高了 6.44%。业务机构的重整也提高了营销的效率,营业费用占主营业务收入的比重由上年的 42.35%下降到本期的 38.67%。因此,收入的增长、毛利率的相对稳定以及费用在收入中的比重下降是净利润增长的保障,主营业务的盈利能力随着九味镇心颗粒产品快速增长将进一步巩固。
    (三)主营业务及其结构发生重大变化的原因说明
    √ 适用 □ 不适用
    药品生产收入较上年增长45.79%,其中对比剂增长43.72%,九味镇心颗粒增长299.53%。九味镇心颗粒产品增幅远远超过对比剂产品,九味镇心颗粒产品收入在收入中的比重由上年同期的1.75%提升到本期的4.80%。九味镇心颗粒产品是目前国内唯一的治疗广泛焦虑症的纯中药处方药品,通过以前的市场培育和学术推广,已逐渐被市场认识和接受,随着推广活动的广泛开展,该产品收入在药品生产收入中的比重将越来越高。
    (四)主营业务盈利能力(毛利率)与上年相比发生重大变化的原因说明
    □ 适用 √ 不适用
    (五)利润构成与上年相比发生重大变化的原因分析
    □ 适用 √ 不适用
    (六)无形资产(商标、专利、非专利技术、土地使用权、水面养殖权、探矿权、采矿权等)发生重大变化的影响因素及重大不利变化的应对措施
    □ 适用 √ 不适用
                                                                                              2012 年半年度报告摘要
       (七)因设备或技术升级换代、核心技术人员辞职、特许经营权丧失等导致公司核心竞争能力受到严重影响的具体情况及公司拟采取的措施
       □ 适用 √ 不适用
       (八)募集资金使用情况
       1、募集资金使用情况对照表
       √ 适用 □ 不适用
                                                                                                          单位:万元
    募集资金总额                                                27,189.11 本报告期
                                                                      投入募集                                2,330.09
    报告期内变更用途的募集资金总额                                      0 资金总额
    累计变更用途的募集资金总额                                  1,992.36 已累计投
                                                                     入募集资                                 9,859.77
    累计变更用途的募集资金总额比例                                7.33% 金总额
                   是否已变                                     截至期末 项目达到                   项目可行
                            募集资金 调整后投          截至期末                   本报告期
    承诺投资项目和超募 更项目                     本报告期          投资进度 预定可使          是否达到 性是否发
                            承诺投资 资总额            累计投入                   实现的效
    资金投向       (含部分                    投入金额          (%)(3)= 用状态日          预计效益 生重大变
                              总额     (1)             金额(2)                      益
                     变更)                                        (2)/(1)    期                       化承诺投资项目新建注射剂车间与对
    比剂营销网络建设项     是         4,413    9,798 1,725.92 5,001.24     51.04% 2013-03-31   2,677.99   否        否目九味镇心颗粒生产线
    扩建改造与营销网络     是         5,000   10,882   499.51 1,966.41     18.07% 2013-12-31   -127.46    否        否建设项目改建研发中心与新产
                       是         2,976    1,896   104.66     814.48   42.96% 2012-12-31          - 不适用      否品开发项目
    承诺投资项目小计       -         12,389   22,576 2,330.09 7,782.13           -    -        2,550.53   -          -超募资金投向
    阿戈美拉汀项目         -           990      990        0       77.64         -    -               - 不适用      否
    归还银行贷款(如有)   -              -        -        -          -         -    -               -   -          -
    补充流动资金(如有)   -          2,000    2,000       0       2,000         -    -               -   -          -
    超募资金投向小计       -          2,990    2,990       0 2,077.64            -    -               -   -          -
    合计                   -         15,379   25,566 2,330.09 9,859.77           -    -        2,550.53   -          -未达到计划进度或预
                   九味镇心颗粒生产线扩建改造因国家新版《药品生产质量管理规范》(GMP)标准下达时间较晚,项计收益的情况和原因
                   目实施延期。(分具体项目)
                   阿戈美拉汀项目可行性发生了重大变化,情况说明如下: 阿戈美拉汀是一个具有全新作用机制的抗
                   抑郁新药,2009 年刚刚在欧洲获得上市许可,为丰富公司精神神经领域的产品,公司计划使用超募资
                   金开发抗抑郁新药--阿戈美拉汀及其片剂。南京华威医药科技有限公司(下称“华威”)完成了阿戈美
                   拉汀的临床前研究工作,经与华威友好洽谈,双方签署协议,华威负责取得阿戈美拉汀及片剂的临床项目可行性发生重大
                   批件,由我公司独家买断华威对该项目的临床前研究技术,之后由我公司独立完成该项目的临床研究、变化的情况说明
                   工艺产业化研究、申报新药证书、生产文号和上市许可等开发工作。上述事项经 2010 年 8 月 3 日召
                   开的公司第三届董事会 2010 年第五次会议以 9 票赞成、0 票反对、0 票弃权审议通过。在《关于超募
                   资金使用计划的议案》,其中,计划使用超募资金 990 万元开发抗抑郁新药--阿戈美拉汀及其片剂。公
                   司监事会、独立董事、保荐机构分别发表了同意意见,2010 年 8 月 31 日,公司 2010 年第二次临时股
                                                                                           2012 年半年度报告摘要
                    东大会审议批准了此项议案。2011 年 5 月,公司接到华威通知,其申报国家食品药品监督管理局药审
                    中心的阿戈美拉汀及其片剂项目技术资料未能通过技术评审而被退审,未取得临床批件。项目的可行
                    性已经发生重大变化,公司已无法按照预先披露的实施计划继续该项目的开发工作。公司研发中心项
                    目组在接到退审通知书后,对项目进行了重新评估,认为如果继续等待华威重新提交临床资料并获得
                    临床批件,将至少多耗费三年时间而且申报的受理等级从原来的三类药降至六类药,且完成临床研究
                    并取得正式注册批件过程中的每个环节都将发生变化,产品将失去上市最佳时机,市场风险增大。 经
                    慎重考虑,公司决定终止阿戈美拉汀项目的相关开发工作。2011 年 8 月 5 日公司 2011 年第一次临时
                    股东大会审议通过了《关于终止阿戈美拉汀项目的议案》。
                    √ 适用 □ 不适用
                    本公司计划募集资金 12,389 万元,实际募集资金净额超过计划募集资金 14,800.11 万元。本公司超募
                    资金安排使用情况如下:
                    1、投入 5,882.00 万元人民币,用于九味镇心颗粒制剂生产线扩建改造与营销网络建设项目所需资金;
                     2、用 2,000.00 万元人民币永久补充公司流动资金;超募资金的金额、用途 3、投入 990.00 万元人民币,用于开发抗抑郁新药--阿戈美拉汀及其片剂项目的资金;及使用进展情况
                     4、投入 4,305.00 万元人民币,用于新建注射剂车间及对比剂营销网络建设项目所需资金;鉴于阿戈
                     美拉汀项目可行性发生了重大变化,2011 年 8 月 5 日公司 2011 年第一次临时股东大会审议通过了《关
                     于终止阿戈美拉汀项目的议案》,该项目计划使用资金 990 万元,目前已投入 77.64 万元,项目未使用
                     的资金 912.36 万元将划拨至未使用超募资金,存放于募集资金专户。公司将根据实际发展情况重新制
                     定超募资金的使用计划,用于公司主业发展,在实际使用前,履行董事会或股东大会审议程序并及时
                     披露。
                   □ 适用 √ 不适用募集资金投资项目实
                   □ 报告期内发生 □ 以前年度发生施地点变更情况
                   □ 适用 √ 不适用募集资金投资项目实
                   □ 报告期内发生 □ 以前年度发生施方式调整情况
                    √ 适用 □ 不适用
                   公司第三届董事会 2010 年第三次会议审议通过《关于用募集资金置换先期投入募投项目的自筹资金募集资金投资项目先 的议案》,同意以募集资金置换预先已投入募集资金投资项目的自筹资金共计 273.33 万元,其中,对
    期投入及置换情况   比剂生产线技术改造与营销网络建设项目 2.34 万元、九味镇心颗粒生产线扩建改造与营销网络建设项
                   目 180.60 万元、新建研发中心与新产品开发项目 90.39 万元。京都天华会计师事务所有限公司已出具
                   京都天华专字(2010)第 0841 号鉴证报告。用闲置募集资金暂时 □ 适用 √ 不适用补充流动资金情况项目实施出现募集资 □ 适用 √ 不适用金结余的金额及原因尚未使用的募集资金 剩余超募资金 1,623.11 万元暂存放于募集资金专户,用于公司主业发展,在实际使用前,履行相应的
    用途及去向         董事会或股东大会审议程序并及时披露。募集资金使用及披露中存在的问题或其他 无情况
    2、变更募集资金投资项目情况表
    □ 适用 √ 不适用
    3、重大非募集资金项目情况
    □ 适用 √ 不适用
                                                                   2012 年半年度报告摘要
    (九)董事会下半年的经营计划修改计划
    □ 适用 √ 不适用
    (十)报告内现金分红政策的执行情况
    √ 适用 □ 不适用
    经京都天华会计师事务所有限公司审计,公司2011年度实现净利润44,211,751.47元,按2011年度公司实现净利润的 10%提取法定盈余公积4,471,869.97元,加年初未分配利润67,343,704.91元,减本年度实施分配2010年度现金股利20,366,547.20元,截至2011年12月31日止,公司可供股东分配利润为86,717,039.21元,期末资本公积余额为228,637,288.68元。
    公司以2011年12月31日公司总股本152,749,104股为基数,按每10股派发现金红利2元(含税),共分配现金股利30,549,820.8元,剩余未分配利润结转以后年度。
    该方案已提交于2012年3月22日召开的公司2011年度股东大会审议通过,并于2012年4月11日实施完毕。
    (十一)预测年初至下一报告期期末的累计净利润可能为亏损、实现扭亏为盈或者与上年同期相比发生大幅度变动的警示及说明
    □ 适用 √ 不适用
    (十二)董事会对会计师事务所本报告期“非标准审计报告”的说明
    □ 适用 √ 不适用
    (十三)公司董事会对会计师事务所上年度“非标准审计报告”涉及事项的变化及处理情况的说明
    □ 适用 √ 不适用
                                  四、重要事项
    (一)重大诉讼仲裁事项
    □ 适用 √ 不适用
                                                                 2012 年半年度报告摘要
    (二)收购、出售资产及资产重组
    1、收购资产
    □ 适用 √ 不适用
    2、出售资产
    □ 适用 √ 不适用
    3、自资产重组报告书或收购出售资产公告刊登后,该事项的进展情况及对报告期经营成果与财务状况的影响
    □ 适用 √ 不适用
    (三)公司报告期内股权激励方案的执行情况,以及对公司报告期及未来财务状况和经营成果影响的说明
    □ 适用 √ 不适用
    (四)重大关联交易
    1、与日常经营相关的关联交易
    □ 适用 √ 不适用
    2、关联债权债务往来
    □ 适用 √ 不适用
    (五)担保事项
    □ 适用 √ 不适用
    (六)证券投资情况
    □ 适用 √ 不适用
    (七)承诺事项履行情况
    √ 适用 □ 不适用
      承诺事项       承诺人                  承诺内容                     履行情况股改承诺
                                                                                           2012 年半年度报告摘要收购报告书或权益变动报告书中所作承诺资产置换时所作承诺
                                       (一)避免同业竞争损害本公司及其他股东的利益,公司控股股
                                       东王代雪做出避免同业竞争的承诺(二)公司股票上市前股东所
                                       持股份的流通限制和自愿锁定股份的承诺。1、公司控股股东、
                                       实际控制人和董事长王代雪、作为公司董事或高级管理人员的洪
                                       薇、段贤柱、武杰、刘宁、李弘等 6 名自然人股东承诺:自公司
                                       股票上市之日起三十六个月内,不转让或者委托他人管理其直接
                                       或者间接持有的公司公开发行股票前已发行的股份,也不由公司
                                       回购其直接或者间接持有的公开发行股票前已发行的股份。2、
                                       作为公司董事、高级管理人员的王代雪、洪薇、段贤柱、武杰、
                                       刘宁、李弘等 6 名自然人股东承诺:在任职期间每年转让的股份
                                       不超过其所持有公司股份总数的 25%;在离职后半年内,不转让
                                       其直接或间接持有的公司股份。3、公司股东姚振萍承诺:自公
                       公司控股股东、
                                       司股票上市之日起十二个月内,不转让或者委托他人管理其直接
                       实际控制人和
                                       或者间接持有的公司公开发行股票前已发行的股份,也不由公司
                       董事长王代雪、
                                       回购其直接或者间接持有的公开发行股票前已发行的股份。4、
                       股东北京科技
                                       公司股东北京科技风险投资股份有限公司承诺:(1)自公司股票
                       风险投资股份
                                       上市之日起十二个月内,不转让或者委托他人管理其直接或间接
                       有限公司、重庆
                                       持有的公司全部股份,也不由公司回购该等股份。(2)在满足上
                       三峡油漆股份                                                               报告期内,各股东
                                       述第(1)项承诺的前提下,自公司股票上市之日起三十六个月
    发行时所作承诺         有限公司、盈富                                                             均遵守了所做的
                                       内,其转让、或委托他人管理、或者由公司回购的其直接或间接
                       泰克创业投资                                                               承诺。
                                       持有的公司股份数量不超过其目前所持公司总股份数的 50%。5、
                       有限公司、股东
                                       公司股东重庆三峡油漆股份有限公司、盈富泰克创业投资有限公
                       姚振萍、董事或
                                       司承诺:(1)自公司股票上市之日起十二个月内,不转让或者委
                       高级管理人员
                                       托他人管理其直接或间接持有的公司全部股份,也不由公司回购
                       的洪薇、段贤
                                       该等股份。(2)在满足上述第(1)项承诺的前提下,自公司股
                       柱、武杰、刘宁、
                                       票上市之日起三十六个月内,其转让、或委托他人管理、或者由
                       李弘等
                                       公司回购的其直接或间接持有的公司股份数量不超过其目前所
                                       持公司总股份数的 60%。(三)控股股东与其他股东一致行动安
                                       排 2009 年 8 月 31 日,控股股东王代雪与洪薇、段贤柱、武杰、
                                       刘宁、李弘签署了《一致行动人协议》,明确在行使股东大会或
                                       董事会等事项的表决之前,一致行动人内部先对表决事项进行协
                                       调;出现意见不一致时,以一致行动人中所持股份最多的股东意
                                       见为准。(四)不签署任何一致行动协议或作出类似安排的承诺
                                       公司股东北京科技科技风险投资股份有限公司、重庆三峡油漆股
                                       份有限公司、盈富泰克创业投资有限公司承诺,其各自为独立的
                                       机构投资者,互相之间不存在关联关系,在作为公司股东期间,
                                       不会签署任何一致行动协议或作出类似安排,也不会做出有损公
                                       司稳定经营和整体利益的行为。其他对公司中小股东所作承诺
                                     五、股本变动及股东情况
    (一)股本变动情况表
    □ 适用 √ 不适用
    限售股份变动情况
    □ 适用 √ 不适用
                                                                                                2012 年半年度报告摘要
       (二)前 10 名股东、前 10 名无限售条件股东持股情况表
    股东总数                                                                                                              9,087前十名股东持股情况
                                            持股比例                       持有有限售条          质押或冻结情况
         股东名称(全称)      股东性质                     持股总数
                                              (%)                            件股份数量      股份状态          数量
    王代雪                           其他         21.13%          32,279,730      32,279,730                                 0
    北京科技风险投资股份有限公司     国有股       15.01%          22,924,830      12,956,115                                 0
    重庆三峡油漆股份有限公司       社会法人股     14.14%          21,593,527       8,637,411                                 0
    盈富泰克创业投资有限公司       社会法人股     11.05%          16,875,000       6,750,000                                 0
    洪薇                             其他          5.12%           7,828,059       7,828,059                                 0中国农业银行—中邮核心优选股
                                 其他          2.47%           3,771,805              0                                  0票型证券投资基金
    姚振萍                           其他          1.97%           3,009,649              0                                  0
    段贤柱                           其他           1.4%           2,137,500       2,137,500                                 0招商银行—中邮核心主题股票型
                                 其他          1.26%           1,928,519              0                                  0证券投资基金
    李祖熙                           其他          0.52%             799,100              0                                  0前十名无限售条件股东持股情况
                                                                                           股份种类及数量
                  股东名称                   持有无限售条件股份数量
                                                                               种类                     数量
    重庆三峡油漆股份有限公司                                      12,956,116       A股                             12,956,116
    盈富泰克创业投资有限公司                                      10,125,000       A股                             10,125,000
    北京科技风险投资股份有限公司                                   9,968,715       A股                              9,968,715中国农业银行—中邮核心优选股票型证券投资
                                                               3,771,805       A股                              3,771,805基金
    姚振萍                                                         3,009,649       A股                              3,009,649
    招商银行—中邮核心主题股票型证券投资基金                       1,928,519       A股                              1,928,519
    李祖熙                                                           799,100       A股                                799,100
    牛雅萱                                                           710,215       A股                                710,215中国农业银行—工银瑞信消费服务行业股票型
                                                                 699,863       A股                                699,863证券投资基金中国农业银行—中邮核心优势灵活配置混合型
                                                                 699,847       A股                                699,847证券投资基金
                                            发起人股东之间不存在关联关系,王代雪、洪薇、段贤柱、武杰、刘宁、李
    上述股东关联关系或(及)一致行动人的说明    弘为本公司一致行动人。公司未知前十名无限售股股东之间是否存在关联关
                                            系,也未知是否属于一致行动人。
       (三)控股股东及实际控制人变更情况
       □ 适用 √ 不适用
                                                                                                 2012 年半年度报告摘要
                                    六、董事、监事和高级管理人员情况
    (一)董事、监事和高级管理人员持股变动
                                                                                                报告期内从    是否在股
                                                                                                公司领取的    东单位或
                                                                   期初持股    期末持股    变动
    姓名           职务        性别   年龄 任期起始日期 任期终止日期                                 报酬总额     其他关联
                                                                   数(股)    数(股)    原因
                                                                                                (万元)(税    单位领取
                                                                                                   前)         薪酬
           董 事 长                     2010-08-31
    王代雪                     男     57                 2013-08-30    32,279,730 32,279,730   —        30.18      否
           总 经 理                     2011-04-08
           董         事                2010-08-31
    段贤柱                     男     48                 2013-08-30     2,137,500 2,137,500    —        24.87      否
           副总经理                     2011-04-08
          董         事
    洪 薇                      女     48    2010-08-31   2013-08-30    7,828,059   7,828,059   —         21.7      否
          副总经理
    苏中俊     董         事   男     54    2010-08-31   2013-08-30            0           0   —            0      是
    王荣梓     董         事   男     59    2010-08-31   2013-08-30            0           0   —            0      是
           董         事                2012-03-22
    武瑞华                     男     47                 2013-08-30            0           0   —        107.5      否
           副总经理                     2010-08-31
    戴建平     独立董事        男     66    2010-08-31   2013-08-30            0           0   —            3      否
    李增祺     独立董事        男     69    2010-08-31   2013-08-30            0           0   —            3      否
    吕发钦     独立董事        男     55    2010-08-31   2013-08-30            0           0   —            3      否
    向   青 监事会主席         女     41    2010-08-31   2013-08-30            0           0   —            0      是
    刘东龙     监         事   男     52    2010-08-31   2013-08-30            0           0   —            0      是
    刘维平     监         事   男     48    2010-08-31   2013-08-30            0           0   —            0      是
    宗   利    职工监事        女     41    2010-08-31   2013-08-30            0           0   —        14.08      否
    郑根昌     职工监事        男     43    2010-08-31   2013-08-30            0           0   —           6.9     否
    武   杰    副总经理        女     40    2010-08-31   2013-08-30      562,500     562,500   —        21.97      否
           副总经理
    刘   宁                    女     49    2010-08-31   2013-08-30      450,000     450,000   —          13.7     否
          董事会秘书
    李   弘    财务总监        男     47    2010-08-31   2013-08-30      450,000     450,000   —          13.7     否
    合计            --          --     --       --           --        43,707,789 43,707,789    --       263.6       --
    董事、监事、高级管理人员报告期内被授予的股权激励情况
    □ 适用 √ 不适用
                                                                            2012 年半年度报告摘要
                                      七、财务会计报告
    (一)审计报告
    半年报是否经过审计
    □ 是 √ 否
    (二)财务报表
    是否需要合并报表:
    √ 是 □ 否1、合并资产负债表编制单位: 北京北陆药业股份有限公司
                                                                                         单位:元
                项目           附注               期末余额                  期初余额流动资产:
    货币资金                    七、1                    249,616,473.19              319,144,109.19
    结算备付金
    拆出资金
    交易性金融资产
    应收票据                    七、3                         2,530,929.44
    应收账款                    七、6                     75,114,237.95                 48,631,381.67
    预付款项                    七、8                     28,976,652.01                 22,884,299.64
    应收保费
    应收分保账款
    应收分保合同准备金
    应收利息
    应收股利
    其他应收款                  七、7                         3,058,412.15               1,767,848.94
    买入返售金融资产
    存货                        七、9                     37,268,997.15                 23,919,450.09
    一年内到期的非流动资产
    其他流动资产
    流动资产合计                                           396,565,701.89              416,347,089.53
                                                      2012 年半年度报告摘要非流动资产:
    发放委托贷款及垫款
    可供出售金融资产
    持有至到期投资
    长期应收款
    长期股权投资         七、15             3,000,000                3,000,000
    投资性房地产         七、16                                   20,984,032.1
    固定资产             七、17         81,139,421.77            60,729,897.19
    在建工程             七、18         29,356,118.56            14,294,798.57
    工程物资
    固定资产清理
    生产性生物资产
    油气资产
    无形资产             七、23          3,476,121.82             3,509,610.18
    开发支出             七、23          3,750,803.54             1,031,584.67
    商誉
    长期待摊费用         七、25          1,576,255.48             1,543,286.12
    递延所得税资产       七、26          2,956,349.72             3,128,787.44
    其他非流动资产       七、28             71,261.21                87,097.07
    非流动资产合计                        125,326,332.1           108,309,093.34
    资产总计                             521,892,033.99           524,656,182.87流动负债:
    短期借款
    向中央银行借款
    吸收存款及同业存放
    拆入资金
    交易性金融负债
    应付票据
    应付账款             七、32          3,737,717.06             1,704,798.16
    预收款项             七、33           109,181.53               551,050.97
    卖出回购金融资产款
    应付手续费及佣金
    应付职工薪酬         七、34          2,159,624.24              1,322,911.8
    应交税费             七、35          6,732,831.62            10,714,442.85
    应付利息
    应付股利
                                                                               2012 年半年度报告摘要
    其他应付款                       七、38                 3,233,648.83                 1,450,143.83
    应付分保账款
    保险合同准备金
    代理买卖证券款
    代理承销证券款
    一年内到期的非流动负债
    其他流动负债                     七、41                       550,000                   3,207,631
    流动负债合计                                             16,523,003.28                18,950,978.61
    非流动负债:
    长期借款
    应付债券
    长期应付款
    专项应付款
    预计负债
    递延所得税负债
    其他非流动负债                   七、46                  14,235,000                   14,235,000
    非流动负债合计                                             14,235,000                   14,235,000
    负债合计                                                 30,758,003.28                33,185,978.61
    所有者权益(或股东权益):
    实收资本(或股本)               七、47                 152,749,104                  152,749,104
    资本公积                         七、50               228,637,288.68               228,637,288.68
    减:库存股
    专项储备
    盈余公积                         七、51                23,366,772.37                23,366,772.37
    一般风险准备
    未分配利润                       七、53                86,380,865.66                86,717,039.21
    外币报表折算差额
    归属于母公司所有者权益合计                                491,134,030.71               491,470,204.26
    少数股东权益
    所有者权益(或股东权益)合计                              491,134,030.71               491,470,204.26
    负债和所有者权益(或股东权益)总计                        521,892,033.99               524,656,182.87
    法定代表人:王代雪                     主管会计工作负责人:李弘             会计机构负责人:李弘
                                                                     2012 年半年度报告摘要2、母公司资产负债表
                项目         附注          期末余额                   期初余额流动资产:
    货币资金                                      249,488,377.12                  318,891,718.5
    交易性金融资产
    应收票据                                           2,530,929.44
    应收账款                 十五、1               75,114,237.95                  48,631,381.67
    预付款项                                       28,976,652.01                  22,884,299.64
    应收利息
    应收股利
    其他应收款               十五、2                   3,058,412.15                1,767,848.94
    存货                                           37,268,997.15                  23,919,450.09
    一年内到期的非流动资产
    其他流动资产
    流动资产合计                                    396,437,605.82              416,094,698.84非流动资产:
    可供出售金融资产
    持有至到期投资
    长期应收款
    长期股权投资             十五、3                     4,066,159                   4,066,159
    投资性房地产                                                                   20,984,032.1
    固定资产                                       80,612,450.92                  60,100,521.62
    在建工程                                       29,356,118.56                  14,294,798.57
    工程物资
    固定资产清理
    生产性生物资产
    油气资产
    无形资产                                           3,476,121.82                3,509,610.18
    开发支出                                           3,750,803.54                1,031,584.67
    商誉
    长期待摊费用                                       1,576,255.48                1,543,286.12
    递延所得税资产                                     2,956,349.72                3,128,787.44
    其他非流动资产                                       71,261.21                   87,097.07
    非流动资产合计                                  125,865,520.25              108,745,876.77
    资产总计                                        522,303,126.07              524,840,575.61
                                                           2012 年半年度报告摘要流动负债:
    短期借款
    交易性金融负债
    应付票据
    应付账款                                  3,737,717.06             1,704,798.16
    预收款项                                   109,181.53                551,050.97
    应付职工薪酬                              2,144,043.69             1,309,616.95
    应交税费                                  6,732,831.62            10,714,442.85
    应付利息
    应付股利
    其他应付款                                3,210,798.83             1,427,293.83
    一年内到期的非流动负债
    其他流动负债                                  550,000                 3,207,631
    流动负债合计                               16,484,572.73            18,914,833.76非流动负债:
    长期借款
    应付债券
    长期应付款
    专项应付款
    预计负债
    递延所得税负债
    其他非流动负债                             14,235,000                14,235,000
    非流动负债合计                               14,235,000                14,235,000
    负债合计                                   30,719,572.73            33,149,833.76所有者权益(或股东权益):
    实收资本(或股本)                        152,749,104               152,749,104
    资本公积                                228,544,977.58           228,544,977.58
    减:库存股
    专项储备
    盈余公积                                 23,366,772.37            23,366,772.37
    未分配利润                               86,922,699.39             87,029,887.9
    外币报表折算差额
    所有者权益(或股东权益)合计              491,583,553.34           491,690,741.85
    负债和所有者权益(或股东权益)总计        522,303,126.07           524,840,575.61
                                                                                            2012 年半年度报告摘要3、合并利润表
                                                                                                         单位:元
                         项目                         附注          本期金额                    上期金额
    一、营业总收入                                       七、54                 126,890,389                 88,714,242.47
    其中:营业收入                                   七、54                 126,890,389                 88,714,242.47
          利息收入
          已赚保费
          手续费及佣金收入
    二、营业总成本                                       七、54            32,062,134.38                     22,046,755.5
    其中:营业成本                                   七、54            32,062,134.38                     22,046,755.5
          利息支出
          手续费及佣金支出
          退保金
          赔付支出净额
          提取保险合同准备金净额
          保单红利支出
          分保费用
          营业税金及附加                             七、56             1,309,234.27                      954,130.33
          销售费用                                                     48,816,798.94                    36,670,286.66
          管理费用                                                     11,924,319.02                     8,203,549.81
          财务费用                                                     -1,884,317.29                    -1,941,815.01
          资产减值损失                               七、59             1,891,182.21                      718,029.52
    加    :公允价值变动收益(损失以“-”号填列)
          投资收益(损失以“-”号填列)
          其中:对联营企业和合营企业的投资收益
          汇兑收益(损失以“-”号填列)
    三、营业利润(亏损以“-”号填列)                                     32,771,037.47                    22,063,305.66
    加   :营业外收入                                七、60                   2,660,131                    1,051,460
    减   :营业外支出                                七、61                  273,893.92                      157,977
          其中:非流动资产处置损失
    四、利润总额(亏损总额以“-”号填列)                                 35,157,274.55                    22,956,788.66
    减:所得税费用                                   七、62             5,081,732.01                     3,373,918.72
    五、净利润(净亏损以“-”号填列)                                     30,075,542.54                    19,582,869.94
    其中:被合并方在合并前实现的净利润
    归属于母公司所有者的净利润                                         30,075,542.54                    19,582,869.94
    少数股东损益
    六、每股收益:                                                         --                          --
    (一)基本每股收益                                                              0.2                          0.13
    (二)稀释每股收益                                                              0.2                          0.13七、其他综合收益
    八、综合收益总额                                                       30,075,542.54                    19,582,869.94
    归属于母公司所有者的综合收益总额                                   30,075,542.54                    19,582,869.94
    归属于少数股东的综合收益总额本期无发生企业合并事项
    法定代表人:王代雪                       主管会计工作负责人:李弘                         会计机构负责人:李弘
                                                                                     2012 年半年度报告摘要4、母公司利润表
                                                                                                  单位:元
                   项目                      附注          本期金额                   上期金额
    一、营业收入                                十五、4                   126,890,389                88,670,823.67
    减:营业成本                            十五、4                32,062,134.38                 22,005,729.86
           营业税金及附加                                             1,309,234.27                 954,097.78
           销售费用                                                48,816,798.94                 36,670,286.66
           管理费用                                                   11,694,864.5                7,946,104.13
           财务费用                                                -1,883,847.81                 -1,940,762.31
           资产减值损失                                               1,891,182.21                 718,029.52
    加:公允价值变动收益(损失以“-”号填列)
           投资收益(损失以“-”号填列)
           其中:对联营企业和合营企业的投资收益
    二、营业利润(亏损以“-”号填列)                                 33,000,022.51                 22,317,338.03
    加:营业外收入                                                      2,660,131                   1,051,460
    减:营业外支出                                                     273,893.92                     157,977
           其中:非流动资产处置损失
    三、利润总额(亏损总额以“-”号填列)                             35,386,259.59                 23,210,821.03
    减:所得税费用                                                    5,081,732.01                3,373,918.72
    四、净利润(净亏损以“-”号填列)                                 30,304,527.58                 19,836,902.31
    五、每股收益:                                                --                         --
    (一)基本每股收益
    (二)稀释每股收益六、其他综合收益
    七、综合收益总额                                                   30,304,527.58                 19,836,902.31
                                                                   2012 年半年度报告摘要5、合并现金流量表
                                                                               单位:元
               项目                    本期金额                    上期金额一、经营活动产生的现金流量:
    销售商品、提供劳务收到的现金                  115,174,358.72              86,612,559.74
    客户存款和同业存放款项净增加额
    向中央银行借款净增加额
    向其他金融机构拆入资金净增加额
    收到原保险合同保费取得的现金
    收到再保险业务现金净额
    保户储金及投资款净增加额
    处置交易性金融资产净增加额
    收取利息、手续费及佣金的现金
    拆入资金净增加额
    回购业务资金净增加额
    收到的税费返还
    收到其他与经营活动有关的现金                    4,772,135.28               9,922,690.75
    经营活动现金流入小计                                119,946,494               96,535,250.49
    购买商品、接受劳务支付的现金                   49,521,768.99              26,453,965.44
    客户贷款及垫款净增加额
    存放中央银行和同业款项净增加额
    支付原保险合同赔付款项的现金
    支付利息、手续费及佣金的现金
    支付保单红利的现金
    支付给职工以及为职工支付的现金                    14,110,276               9,216,400.06
    支付的各项税费                                 23,208,077.26              14,135,017.89
    支付其他与经营活动有关的现金                   50,211,665.19              33,906,427.75
    经营活动现金流出小计                              137,051,787.44              83,711,811.14
    经营活动产生的现金流量净额                        -17,105,293.44              12,823,439.35二、投资活动产生的现金流量:
    收回投资收到的现金
    取得投资收益所收到的现金
    处置固定资产、无形资产和其他长期资产收回的现金净额
    处置子公司及其他营业单位收到的现金净额
    收到其他与投资活动有关的现金
    投资活动现金流入小计                                          0                          0
    购建固定资产、无形资产和其他长期
                                                    21,081,029.7               7,703,483.27资产支付的现金
    投资支付的现金
    质押贷款净增加额
    取得子公司及其他营业单位支付的
                                                              2012 年半年度报告摘要现金净额
    支付其他与投资活动有关的现金
    投资活动现金流出小计                           21,081,029.7             7,703,483.27
    投资活动产生的现金流量净额                    -21,081,029.7             -7,703,483.27三、筹资活动产生的现金流量:
    吸收投资收到的现金
    其中:子公司吸收少数股东投资收到的现金
    取得借款收到的现金
    发行债券收到的现金
    收到其他与筹资活动有关的现金
    筹资活动现金流入小计                                     0                         0
    偿还债务支付的现金
    分配股利、利润或偿付利息支付的现
                                              31,341,312.86             20,366,547.2金
    其中:子公司支付给少数股东的股利、利润
    支付其他与筹资活动有关的现金
    筹资活动现金流出小计                          31,341,312.86             20,366,547.2
    筹资活动产生的现金流量净额                   -31,341,312.86             -20,366,547.2四、汇率变动对现金及现金等价物的影响
    五、现金及现金等价物净增加额                    -69,527,636            -15,246,591.12
    加:期初现金及现金等价物余额            319,144,109.19           311,421,080.06
    六、期末现金及现金等价物余额                 249,616,473.19           296,174,488.94
                                                                               2012 年半年度报告摘要6、母公司现金流量表
                                                                                            单位:元
                     项目                           本期金额                    上期金额一、经营活动产生的现金流量:
    销售商品、提供劳务收到的现金                           115,174,358.72                  86,561,759.74
    收到的税费返还
    收到其他与经营活动有关的现金                                 4,771,665.8                9,977,252.72
    经营活动现金流入小计                                       119,946,024.52                  96,539,012.46
    购买商品、接受劳务支付的现金                               49,521,768.99               26,405,965.44
    支付给职工以及为职工支付的现金                              13,987,081.9                 9,063,075.8
    支付的各项税费                                             23,208,077.26                14,134,578.5
    支付其他与经营活动有关的现金                               50,210,095.19               33,952,635.61
    经营活动现金流出小计                                       136,927,023.34                  83,556,255.35
    经营活动产生的现金流量净额                                 -16,980,998.82                  12,982,757.11二、投资活动产生的现金流量:
    收回投资收到的现金
    取得投资收益所收到的现金
    处置固定资产、无形资产和其他长期资产收回的现金净额
    处置子公司及其他营业单位收到的现金净额
    收到其他与投资活动有关的现金投资活动现金流入小计
    购建固定资产、无形资产和其他长期资产支付
                                                                21,081,029.7                7,703,483.27的现金
    投资支付的现金
    取得子公司及其他营业单位支付的现金净额
    支付其他与投资活动有关的现金
    投资活动现金流出小计                                            21,081,029.7                7,703,483.27
    投资活动产生的现金流量净额                                     -21,081,029.7               -7,703,483.27三、筹资活动产生的现金流量:
    吸收投资收到的现金
    取得借款收到的现金
    收到其他与筹资活动有关的现金筹资活动现金流入小计
    偿还债务支付的现金
    分配股利、利润或偿付利息支付的现金                         31,341,312.86                20,366,547.2
    支付其他与筹资活动有关的现金
    筹资活动现金流出小计                                           31,341,312.86                20,366,547.2
    筹资活动产生的现金流量净额                                 -31,341,312.86                  -20,366,547.2四、汇率变动对现金及现金等价物的影响
    五、现金及现金等价物净增加额                               -69,403,341.38               -15,087,273.36
    加:期初现金及现金等价物余额                               318,891,718.5               310,858,235.8
    六、期末现金及现金等价物余额                               249,488,377.12              295,770,962.44
                                                                                                                                          2012 年半年度报告摘要7、合并所有者权益变动表本期金额
                                                                                                                                                       单位:元
                                                                                                 本期金额
                                                                            归属于母公司所有者权益
                   项目                                                                                                                               所有者权益合
                                            实收资本                                                一般风险准                         少数股东权益
                                                         资本公积 减:库存股 专项储备   盈余公积               未分配利润       其他                      计
                                           (或股本)                                                   备
    一、上年年末余额                           152,749,104 228,637,288.68                 23,366,772.37            86,717,039.21                          491,470,204.26
    加:会计政策变更
        前期差错更正
        其他
    二、本年年初余额                          152,749,104 228,637,288.68                    23,366,772.37           86,717,039.21                         491,470,204.26
    三、本期增减变动金额(减少以“-”号填列)                                                                        -336,173.55                            -336,173.55
    (一)净利润                                                                                                    30,075,542.54                          30,075,542.54(二)其他综合收益
    上述(一)和(二)小计                                                                                          30,075,542.54                          30,075,542.54(三)所有者投入和减少资本1.所有者投入资本2.股份支付计入所有者权益的金额3.其他
    (四)利润分配                                                                                                 -30,411,716.09                         -30,411,716.091.提取盈余公积2.提取一般风险准备
    3.对所有者(或股东)的分配                                                                                     -30,549,820.8                          -30,549,820.8
    4.其他                                                                                                           138,104.71                             138,104.71(五)所有者权益内部结转1.资本公积转增资本(或股本)2.盈余公积转增资本(或股本)3.盈余公积弥补亏损4.其他
    (六)专项储备1.本期提取2.本期使用(七)其他
    四、本期期末余额                          152,749,104 228,637,288.68                    23,366,772.37           86,380,865.66                         491,134,030.71
                                                                                                                                               2012 年半年度报告摘要上年金额
                                                                                                                                                             单位:元
                                                                                                    上年金额
                                                                               归属于母公司所有者权益
                项目                                                                                                                       少数股东权     所有者权益合
                                        实收资本(或                               专项                 一般风险
                                                         资本公积      减:库存股          盈余公积                未分配利润       其他       益               计
                                           股本)                                  储备                   准备
    一、上年年末余额                          101,832,736   279,553,656.68                     18,894,902.4            67,343,704.91             27,232.81     467,652,232.8
    加:同一控制下企业合并产生的追溯调整
    加:会计政策变更
         前期差错更正
         其他
    二、本年年初余额                         101,832,736    279,553,656.68                    18,894,902.4             67,343,704.91             27,232.81     467,652,232.8三、本期增减变动金额(减少以“-”号
                                          50,916,368       -50,916,368                    4,471,869.97              19,373,334.3             -27,232.81    23,817,971.46填列)
    (一)净利润                                                                                                       44,211,751.47             -18,317.06    44,193,434.41(二)其他综合收益
    上述(一)和(二)小计                                                                                             44,211,751.47             -18,317.06    44,193,434.41
    (三)所有者投入和减少资本                                                                                                                    -8,915.75        -8,915.75
    1.所有者投入资本                                                                                                                             -8,915.75        -8,915.752.股份支付计入所有者权益的金额3.其他
    (四)利润分配                                                                            4,471,869.97             -24,838,417.17                          -20,366,547.2
    1.提取盈余公积                                                                           4,471,869.97              -4,471,869.972.提取一般风险准备
    3.对所有者(或股东)的分配                                                                                         -20,366,547.2                          -20,366,547.24.其他
    (五)所有者权益内部结转                  50,916,368       -50,916,368
    1.资本公积转增资本(或股本)             50,916,368       -50,916,3682.盈余公积转增资本(或股本)3.盈余公积弥补亏损4.其他
    (六)专项储备1.本期提取2.本期使用(七)其他
    四、本期期末余额                         152,749,104    228,637,288.68                   23,366,772.37             86,717,039.21                          491,470,204.26
                                                                                                                                          2012 年半年度报告摘要8、母公司所有者权益变动表本期金额
                                                                                                                                                       单位:元
                                                                                              本期金额
                  项目                   实收资本(或股                                                                                          所有者权益合
                                                           资本公积       减:库存股   专项储备      盈余公积       一般风险准备   未分配利润
                                              本)                                                                                                    计
    一、上年年末余额                             152,749,104 228,544,977.58                             23,366,772.37                   87,029,887.9 491,690,741.85
    加:会计政策变更
        前期差错更正
        其他
    二、本年年初余额                             152,749,104 228,544,977.58                             23,366,772.37                   87,029,887.9 491,690,741.85
    三、本期增减变动金额(减少以“-”号填列)                                                                                           -107,188.51    -107,188.51
    (一)净利润                                                                                                                       30,304,527.58 30,304,527.58(二)其他综合收益
    上述(一)和(二)小计                                                                                                             30,304,527.58    30,304,527.58(三)所有者投入和减少资本1.所有者投入资本2.股份支付计入所有者权益的金额3.其他
    (四)利润分配                                                                                                                     -30,411,716.09   -30,411,716.091.提取盈余公积2.提取一般风险准备
    3.对所有者(或股东)的分配                                                                                                         -30,549,820.8    -30,549,820.8
    4.其他                                                                                                                               138,104.71       138,104.71(五)所有者权益内部结转1.资本公积转增资本(或股本)2.盈余公积转增资本(或股本)3.盈余公积弥补亏损4.其他
    (六)专项储备1.本期提取2.本期使用(七)其他
    四、本期期末余额                             152,749,104 228,544,977.58                             23,366,772.37                  86,922,699.39 491,583,553.34
                                                                                                                                         2012 年半年度报告摘要上年金额
                                                                                                                                                       单位:元
                                                                                              上年金额
                    项目                 实收资本(或股                                                                                             所有者权益合
                                                           资本公积       减:库存股   专项储备      盈余公积       一般风险准备   未分配利润
                                             本)                                                                                                       计
    一、上年年末余额                             101,832,736 279,461,345.58                              18,894,902.4                  67,149,605.38 467,338,589.36
    加:会计政策变更
          前期差错更正
          其他
    二、本年年初余额                             101,832,736 279,461,345.58                              18,894,902.4                  67,149,605.38 467,338,589.36
    三、本期增减变动金额(减少以“-”号填列)    50,916,368    -50,916,368                              4,471,869.97                  19,880,282.52     24,352,152.49
    (一)净利润                                                                                                                       44,718,699.69     44,718,699.69(二)其他综合收益
    上述(一)和(二)小计                                                                                                             44,718,699.69     44,718,699.69(三)所有者投入和减少资本1.所有者投入资本2.股份支付计入所有者权益的金额3.其他
    (四)利润分配                                                                                       4,471,869.97                  -24,838,417.17    -20,366,547.2
    1.提取盈余公积                                                                                      4,471,869.97                   -4,471,869.972.提取一般风险准备
    3.对所有者(或股东)的分配                                                                                                         -20,366,547.2    -20,366,547.24.其他
    (五)所有者权益内部结转                      50,916,368    -50,916,368
    1.资本公积转增资本(或股本)                 50,916,368    -50,916,3682.盈余公积转增资本(或股本)3.盈余公积弥补亏损4.其他(六)专项储备1.本期提取2.本期使用(七)其他
    四、本期期末余额                             152,749,104 228,544,977.58                             23,366,772.37                   87,029,887.9 491,690,741.85
                                                            2012 年半年度报告摘要(三)报表附注1、主要会计政策、会计估计的变更以及重大会计差错更正及其影响数(1)会计政策变更本报告期主要会计政策是否变更□ 是 √ 否(2)会计估计变更本报告期主要会计估计是否变更□ 是 √ 否(3)会计差错更正本报告期是否发现前期会计差错□ 是 √ 否2、合并报表合并范围发生变更的理由无3、被出具非标准审计报告,列示涉及事项的有关附注无
数据加载中...
prevnext
手机查看股票